CHE:NYE-Chemed Corp (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 574.76

Change

+5.54 (+0.97)%

Market Cap

USD 2.38B

Volume

0.04M

Analyst Target

USD 565.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Chemed Corp through its subsidiary, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+3.50 (+0.96%)

USD 105.82B
THC Tenet Healthcare Corporation

+4.49 (+2.77%)

USD 15.44B
UHS Universal Health Services Inc

+3.34 (+1.60%)

USD 13.69B
DVA DaVita HealthCare Partners Inc

+2.14 (+1.48%)

USD 11.58B
EHC Encompass Health Corp

+1.11 (+1.11%)

USD 9.63B
CON Concentra Group Holdings Paren..

-0.63 (-3.12%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.46 (+2.62%)

USD 2.59B
NHC National HealthCare Corporatio..

+4.13 (+3.54%)

USD 1.83B
AMN AMN Healthcare Services Inc

+1.25 (+3.26%)

USD 1.46B
BKD Brookdale Senior Living Inc

+0.02 (+0.32%)

USD 1.25B

ETFs Containing CHE

OSCV 2.29 % 0.79 %

N/A

N/A
HLTH:AU VanEck Global Healthcare .. 2.13 % 0.00 %

+0.02 (+0%)

USD 0.06B
XHS SPDR® S&P Health Care Se.. 2.12 % 0.35 %

+0.94 (+0%)

USD 0.08B
OUSM 2.03 % 0.48 %

N/A

N/A
EQWM Invesco S&P MidCap Qualit.. 0.00 % 0.25 %

N/A

N/A
OLD 0.00 % 0.50 %

N/A

N/A
JELS:LSE 0.00 % 0.00 %

N/A

N/A
TQSM:CA TD Q U.S. Small-Mid-Cap E.. 0.00 % 0.00 %

+0.34 (+0%)

CAD 0.19B
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.71% 36% F 24% F
Dividend Return 0.22% 13% F 4% F
Total Return -1.49% 36% F 21% F
Trailing 12 Months  
Capital Gain 12.20% 45% F 53% F
Dividend Return 0.33% 13% F 4% F
Total Return 12.53% 45% F 44% F
Trailing 5 Years  
Capital Gain 36.29% 56% F 66% D+
Dividend Return 1.66% 14% F 4% F
Total Return 37.95% 56% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.17% 45% F 60% D-
Dividend Return 6.45% 41% F 53% F
Total Return 0.28% 13% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 9.56% 100% F 79% B-
Risk Adjusted Return 67.41% 91% A- 83% B
Market Capitalization 2.38B 74% C 84% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.50 7% 25%
Price/Book Ratio 7.10 29% 13%
Price / Cash Flow Ratio 25.94 16% 11%
Price/Free Cash Flow Ratio 18.82 11% 19%
Management Effectiveness  
Return on Equity 27.87% 76% 91%
Return on Invested Capital 26.24% 100% 93%
Return on Assets 14.13% 100% 98%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.